NCT02019706View on ClinicalTrials.gov

Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 12, 2014

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
ACTHCushing's Syndrome
Interventions
RADIATION

DOTATATE PET-CT

68Ga-DOTATATE PET/CT

RADIATION

F-DOPA PET CT

68Ga-DOTATATE PET/CT

RADIATION

CT scan

routine CT scan

DIAGNOSTIC_TEST

Routine MRI scan

routine 1.5 or 3T MRI scan

DIAGNOSTIC_TEST

Gated MRI scan

Cardiac gated MRI scan

DRUG

68Ga-DOTATATE

68Ga-DOTATATE radioligand

DRUG

18F-DOPA

18F-DOPA radioligand

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH